ID   CL1-5-F4-Luc
AC   CVCL_A5BR
SY   F4-Luc
DR   Wikidata; Q107114690
RX   PubMed=19597463;
RX   PubMed=25060522;
CC   Population: Chinese; Taiwan.
CC   Transfected with: UniProtKB; P08659; Firefly luciferase.
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IN56 ! CL1-5-F4
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
RX   PubMed=19597463; DOI=10.1038/onc.2009.187;
RA   Sher Y.-P., Tzeng T.-F., Kan S.-F., Hsu J.L., Xie X., Han Z., Lin W.-C.,
RA   Li L.-Y., Hung M.-C.;
RT   "Cancer targeted gene therapy of BikDD inhibits orthotopic lung cancer
RT   growth and improves long-term survival.";
RL   Oncogene 28:3286-3295(2009).
//
RX   PubMed=25060522; DOI=10.1158/0008-5472.CAN-13-2995;
RA   Lin C.-Y., Chen H.-J., Huang C.-C., Lai L.-C., Lu T.-P., Tseng G.-C.,
RA   Kuo T.-T., Kuok Q.-Y., Hsu J.L., Sung S.-Y., Hung M.-C., Sher Y.-P.;
RT   "ADAM9 promotes lung cancer metastases to brain by a plasminogen
RT   activator-based pathway.";
RL   Cancer Res. 74:5229-5243(2014).
//